CRWD: 27% | CrowdStrike Holdings shares are trading higher after the company reported better-than-expected Q4 earnings and revenues and issued upbeat guidance for Q1 and FY25. Some analysts raised their price targets on the stock following the report.

CELZ: 85% | Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

MEDS: 67% | TRxADE Health, Inc. Announces Special Cash Dividend Of $8/Share